ENO2 and lung cancer: Comnea-Stancu et al. (20) proposed a random sensor based on maltodextrin with different glucose equivalents for the determination of three lung cancer biomarkers: neuron-specific enolase, carcinoembryonic antigen, and epidermal growth factor receptor.